246 related articles for article (PubMed ID: 27903597)
1. Impact of Organic Cation Transporters (OCT-SLC22A) on Differential Diagnosis of Intrahepatic Lesions.
Visentin M; van Rosmalen BV; Hiller C; Bieze M; Hofstetter L; Verheij J; Kullak-Ublick GA; Koepsell H; Phoa SS; Tamai I; Bennink RJ; van Gulik TM; Stieger B
Drug Metab Dispos; 2017 Feb; 45(2):166-173. PubMed ID: 27903597
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significance.
Heise M; Lautem A; Knapstein J; Schattenberg JM; Hoppe-Lotichius M; Foltys D; Weiler N; Zimmermann A; Schad A; Gründemann D; Otto G; Galle PR; Schuchmann M; Zimmermann T
BMC Cancer; 2012 Mar; 12():109. PubMed ID: 22439694
[TBL] [Abstract][Full Text] [Related]
3. The use of 18F-fluoromethylcholine PET/CT in differentiating focal nodular hyperplasia from hepatocellular adenoma: a prospective study of diagnostic accuracy.
Bieze M; Bennink RJ; El-Massoudi Y; Phoa SS; Verheij J; Beuers U; van Gulik TM
Nucl Med Commun; 2013 Feb; 34(2):146-54. PubMed ID: 23154640
[TBL] [Abstract][Full Text] [Related]
4. Functional characterization of the organic cation transporters (OCTs) in human airway pulmonary epithelial cells.
Ingoglia F; Visigalli R; Rotoli BM; Barilli A; Riccardi B; Puccini P; Dall'Asta V
Biochim Biophys Acta; 2015 Jul; 1848(7):1563-72. PubMed ID: 25883089
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of organic cation transporter 1 (SLC22A1) is associated with tumor progression and reduced patient survival in human cholangiocellular carcinoma.
Lautem A; Heise M; Gräsel A; Hoppe-Lotichius M; Weiler N; Foltys D; Knapstein J; Schattenberg JM; Schad A; Zimmermann A; Otto G; Lang H; Galle PR; Schuchmann M; Zimmermann T
Int J Oncol; 2013 Apr; 42(4):1297-304. PubMed ID: 23440379
[TBL] [Abstract][Full Text] [Related]
6. Inter-Subject Variability in OCT1 Activity in 27 Batches of Cryopreserved Human Hepatocytes and Association with OCT1 mRNA Expression and Genotype.
Fattah S; Shinde AB; Matic M; Baes M; van Schaik RHN; Allegaert K; Parmentier C; Richert L; Augustijns P; Annaert P
Pharm Res; 2017 Jun; 34(6):1309-1319. PubMed ID: 28364304
[TBL] [Abstract][Full Text] [Related]
7. Characterization of human organic cation transporter 1 (OCT1/SLC22A1)- and OCT2 (SLC22A2)-mediated transport of 1-(2-methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)- 4,9-dihydro-1H-naphtho[2,3-d]imidazolium bromide (YM155 monobromide), a novel small molecule survivin suppressant.
Minematsu T; Iwai M; Umehara K; Usui T; Kamimura H
Drug Metab Dispos; 2010 Jan; 38(1):1-4. PubMed ID: 19833842
[TBL] [Abstract][Full Text] [Related]
8. Metformin is a superior substrate for renal organic cation transporter OCT2 rather than hepatic OCT1.
Kimura N; Masuda S; Tanihara Y; Ueo H; Okuda M; Katsura T; Inui K
Drug Metab Pharmacokinet; 2005 Oct; 20(5):379-86. PubMed ID: 16272756
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy of (18) F-methylcholine positron emission tomography/computed tomography for intra- and extrahepatic hepatocellular carcinoma.
Bieze M; Klümpen HJ; Verheij J; Beuers U; Phoa SS; van Gulik TM; Bennink RJ
Hepatology; 2014 Mar; 59(3):996-1006. PubMed ID: 24123111
[TBL] [Abstract][Full Text] [Related]
10. Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver.
Nies AT; Koepsell H; Winter S; Burk O; Klein K; Kerb R; Zanger UM; Keppler D; Schwab M; Schaeffeler E
Hepatology; 2009 Oct; 50(4):1227-40. PubMed ID: 19591196
[TBL] [Abstract][Full Text] [Related]
11. Imatinib Uptake into Cells is Not Mediated by Organic Cation Transporters OCT1, OCT2, or OCT3, But is Influenced by Extracellular pH.
Blanc Mettral J; Faller N; Cruchon S; Sottas L; Buclin T; Schild L; Choong E; Nahimana A; Decosterd LA
Drug Metab Lett; 2019; 13(2):102-110. PubMed ID: 30734690
[TBL] [Abstract][Full Text] [Related]
12. Protein Kinase C-Independent Inhibition of Organic Cation Transporter 1 Activity by the Bisindolylmaleimide Ro 31-8220.
Mayati A; Bruyere A; Moreau A; Jouan E; Denizot C; Parmentier Y; Fardel O
PLoS One; 2015; 10(12):e0144667. PubMed ID: 26657401
[TBL] [Abstract][Full Text] [Related]
13. Stereoselective cell uptake of adrenergic agonists and antagonists by organic cation transporters.
Jensen O; Rafehi M; Tzvetkov MV; Brockmöller J
Biochem Pharmacol; 2020 Jan; 171():113731. PubMed ID: 31783011
[TBL] [Abstract][Full Text] [Related]
14. Proton pump inhibitors inhibit metformin uptake by organic cation transporters (OCTs).
Nies AT; Hofmann U; Resch C; Schaeffeler E; Rius M; Schwab M
PLoS One; 2011; 6(7):e22163. PubMed ID: 21779389
[TBL] [Abstract][Full Text] [Related]
15. Renal uptake of substrates for organic anion transporters Oat1 and Oat3 and organic cation transporters Oct1 and Oct2 is altered in rats with adenine-induced chronic renal failure.
Komazawa H; Yamaguchi H; Hidaka K; Ogura J; Kobayashi M; Iseki K
J Pharm Sci; 2013 Mar; 102(3):1086-94. PubMed ID: 23280877
[TBL] [Abstract][Full Text] [Related]
16. Tissue distribution and ontogeny of organic cation transporters in mice.
Alnouti Y; Petrick JS; Klaassen CD
Drug Metab Dispos; 2006 Mar; 34(3):477-82. PubMed ID: 16381671
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of organic cation transporter (OCT) activities by carcinogenic heterocyclic aromatic amines.
Sayyed K; Camillerapp C; Le Vée M; Bruyère A; Nies AT; Abdel-Razzak Z; Fardel O
Toxicol In Vitro; 2019 Feb; 54():10-22. PubMed ID: 30189235
[TBL] [Abstract][Full Text] [Related]
18. Interplay of the Organic Cation Transporters OCT1 and OCT2 with the Apically Localized Export Protein MATE1 for the Polarized Transport of Trospium.
Deutsch B; Neumeister C; Schwantes U; Fromm MF; König J
Mol Pharm; 2019 Feb; 16(2):510-517. PubMed ID: 30656943
[TBL] [Abstract][Full Text] [Related]
19. Deficiency in the organic cation transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in mice abolishes renal secretion of organic cations.
Jonker JW; Wagenaar E; Van Eijl S; Schinkel AH
Mol Cell Biol; 2003 Nov; 23(21):7902-8. PubMed ID: 14560032
[TBL] [Abstract][Full Text] [Related]
20. Irinotecan Alters the Disposition of Morphine Via Inhibition of Organic Cation Transporter 1 (OCT1) and 2 (OCT2).
Zhu P; Ye Z; Guo D; Xiong Z; Huang S; Guo J; Zhang W; Polli JE; Zhou H; Li Q; Shu Y
Pharm Res; 2018 Oct; 35(12):243. PubMed ID: 30361780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
